Technical Analysis for VBIV - VBI Vaccines Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 0.63 | 0.64% | 0.00 |
VBIV closed up 0.64 percent on Friday, April 19, 2024, on 30 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | 0.64% | |
Crossed Above 50 DMA | Bullish | 0.64% | |
Wide Bands | Range Expansion | 0.64% | |
Oversold Stochastic | Weakness | 0.64% | |
20 DMA Resistance | Bearish | 4.06% |
Alert | Time |
---|---|
Rose Above 10 DMA | about 6 hours ago |
50 DMA Support | about 7 hours ago |
60 Minute Opening Range Breakdown | about 7 hours ago |
Down 3% | about 7 hours ago |
Fell Below 50 DMA | about 7 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
VBI Vaccines Inc., a biotechnology company, engages in the formulation, development, and delivery of vaccines. It develops Thermostable IM flu vaccine for the needs of pediatric, adult, and geriatric markets; Thermostable IM measles vaccines; Thermostable Oral flu and Shigella vaccines; prophylactic VLP-based vaccines to prevent cytomegalovirus infections and diseases; and seasonal/pandemic influenza vaccines. The company serves customers in the United States and internationally. VBI Vaccines Inc. was formerly known as Variation Biotechnologies (US), Inc. The company was founded in 2001 and is based in Cambridge, Massachusetts with research facilities in Ottawa, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Vaccines Influenza Vaccination Virology Influenza Vaccine Measles Cytomegalovirus Infection Seasonal/Pandemic Influenza Shigella
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Vaccines Influenza Vaccination Virology Influenza Vaccine Measles Cytomegalovirus Infection Seasonal/Pandemic Influenza Shigella
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.47 |
52 Week Low | 0.45 |
Average Volume | 537,028 |
200-Day Moving Average | 0.79 |
50-Day Moving Average | 0.62 |
20-Day Moving Average | 0.64 |
10-Day Moving Average | 0.65 |
Average True Range | 0.10 |
RSI (14) | 50.50 |
ADX | 49.38 |
+DI | 36.37 |
-DI | 7.13 |
Chandelier Exit (Long, 3 ATRs) | 1.06 |
Chandelier Exit (Short, 3 ATRs) | 0.84 |
Upper Bollinger Bands | 0.80 |
Lower Bollinger Band | 0.48 |
Percent B (%b) | 0.48 |
BandWidth | 50.06 |
MACD Line | 0.00 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0068 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.70 | ||||
Resistance 3 (R3) | 0.70 | 0.68 | 0.69 | ||
Resistance 2 (R2) | 0.68 | 0.66 | 0.68 | 0.69 | |
Resistance 1 (R1) | 0.66 | 0.65 | 0.64 | 0.66 | 0.68 |
Pivot Point | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 |
Support 1 (S1) | 0.61 | 0.61 | 0.60 | 0.61 | 0.58 |
Support 2 (S2) | 0.59 | 0.60 | 0.59 | 0.58 | |
Support 3 (S3) | 0.56 | 0.59 | 0.58 | ||
Support 4 (S4) | 0.57 |